Beam Therapeutics (NASDAQ:BEAM) is one of the 17 biotechnology stocks with more than 50% upside. On January 22, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Beam Therapeutics ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Beam Therapeutics (BEAM) is back in focus after securing an expedited FDA approval pathway ...
Hyper Scape feels like something that happened ages ago, but Ubisoft's failed battle royale game was shut down in April 2022 after halting its content updates a year before that. The game itself ...
Self-reliance is often encouraged over asking others for help in the modern world. But doing everything yourself can be a sign that you are scared of intimacy When a relative was seriously ill and in ...
is a deputy editor and Verge co-founder with a passion for human-centric cities, e-bikes, and life as a digital nomad. He’s been a tech journalist for 20 years. Light-based internet provider Taara, ...
While Highguard hasn't been outright cancelled yet, its rocky start — poor reviews, a dwindling player count, and developer layoffs — means it's unlikely to have a promising future. But it isn't the ...
The passions that once drove the left have faded, while the populist right marches on By Anton Jäger In his 2002 memoir Interesting Times, the British historian Eric Hobsbawm offers a succinct ...
As global spirits demand weakens, Japan’s Suntory is leaning on an unexpected growth driver: soft drinks. The beverage giant reported 2025 revenue of ¥3.43 trillion (about $22.3 billion), a 0.4 ...
Andrea is an editor at GameRant, where she has been writing professionally about video games for nearly five years. She became a gamer for life at 8, thanks to a copy of Pokemon Red and her Game Boy.
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results